MedDataX Logo

Improving Employment and Reducing Recidivism Among Prison Offenders Via Virtual Interview Training Tool

NCT03937128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2026-01-22

No results posted yet for this study

Summary

The goal is to conduct a confirmatory effectiveness RCT (and an implementation evaluation) of Virtual Interview Training (VIT) by comparing employment and recidivism outcomes of offenders receiving vocational services as usual (SAU) plus VIT (SAU+VIT) with the outcomes of offenders receiving only services as usual (SAU-only).

The plan calls for participants to include offenders who are at moderate to high risk for reoffending (with an emphasis on violent-crime reoffending) who are currently enrolled in a Vocational Village.

Conditions

  • Criminal Behavior

Interventions

BEHAVIORAL

Virtual Reality Job Interview Training

Participants will engage in training related to preforming well during a job interview as well as repeated job interview practice with a virtual hiring manager. Participants will receive feedback and tips on improving skills throughout the training.

BEHAVIORAL

Services as usual

Study participants will be receiving Vocational Village services as usual that may include but is not limited to vocational skill training, daily living skill training, and social skill training.

Sponsors & Collaborators

  • SIMmersion, LLC

    collaborator INDUSTRY

  • University of Michigan

    lead OTHER

Principal Investigators

  • Matthew J Smith, PhD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-16
Primary Completion
2024-01-01
Completion
2025-12-01

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03937128 on ClinicalTrials.gov